Analgesics and ESRD study results may underestimate risk, researchers write in NEJM.
This article was originally published in The Tan Sheet
ANALGESICS AND ESRD: POSSIBLE MISCLASSIFICATION OF ANALGESICS USAGE AND DOSAGE by participants in a study published in the Dec. 22 New England Journal of Medicine "would bias the odds ratio towards...absence of association," Thomas Perneger, MD/PhD, et al. said in response to a letter in the June 1 NEJM that pointed out the potential for patient confusion. "This arouses concern that, in reality, the risk of [end-stage renal disease] associated with the use of analgesic drugs is higher than we found," Perneger et al. stated.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC